---
title: "Exentis Group AG sells 9 machines in the US"
url: https://www.voxelmatters.com/exentis-group-ag-sells-9-machines-in-the-us/
date: 2024-12-13
modified: 2024-12-13
lang: en
author: "Davide Sher"
description: "Exentis Group AG, the global leader in 3D screen printing for industrial-scale manufacturing, received multiple purchase orders during the fourth quarter of 2024 for nine Exentis 3D production systems destined..."
categories:
  - "3D Printer Hardware"
  - "Financial Reports"
  - "Money & Funding"
tags:
  - "insights"
image: https://www.voxelmatters.com/wp-content/uploads/2024/12/exentis-640x360.jpeg
word_count: 304
---

# Exentis Group AG sells 9 machines in the US

[Exentis Group AG](https://www.voxelmatters.directory/company/exentis-group/), the global leader in 3D screen printing for industrial-scale manufacturing, received multiple purchase orders during the fourth quarter of 2024 for nine Exentis 3D production systems destined for the United States. These sales, amounting to approximately CHF 20 million, mark a crucial step in Exentis’ strategy to penetrate the US market, the world’s largest hub for industrial additive manufacturing technologies.

![Exentis Group AG makes a major move to penetrate the US market with their innovative 3D technology platform for industrial-scale manufacturing.](https://www.voxelmatters.com/wp-content/uploads/2024/02/exentis-3d-screen-printing.jpg)Gürsel Demircali, Chief Commercial Officer of Exentis Group AG, expressed enthusiasm about this achievement, emphasizing the growing recognition of Exentis’ innovative 3D technology platform. He highlighted the platform’s ability to produce millions of ultra-fine industrial parts or pharmaceutical tablets with customizable drug delivery profiles, using a highly sustainable process and a completely free choice of materials or active pharmaceutical ingredients. This flexibility and sustainability are key differentiators in an increasingly competitive market.

This accomplishment brings Exentis’ total US sales in 2024 to ten production systems, reflecting remarkable progress given the company’s recent entry into this strategic market. The success signifies Exentis’ ability to meet diverse industrial needs, from precision engineering to advanced pharmaceutical manufacturing, while appealing to businesses focused on environmentally friendly solutions.

Demand from US customers across a range of industries continues to surpass initial projections. Exentis has noted a surge in ongoing projects, which are expected to yield further development initiatives, contract manufacturing orders, and additional purchase agreements for 3D production systems. These collaborations are anticipated to establish long-term partnerships and expand the company’s technological footprint through license agreements.

The strong momentum in the US market demonstrates the scalability and adaptability of Exentis’ platform. The company’s ability to manufacture high-precision components sustainably positions it as a global frontrunner in industrial additive manufacturing. As Exentis continues to expand its reach, the US market will remain a cornerstone of its growth strategy, paving the way for further innovation and market leadership.